Treg-cell depletion promotes chemokine production and accumulation of CXCR3(+) conventional T cells in intestinal tumors. (Q41441154)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25754875%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

Treg-cell depletion promotes chemokine production and accumulation of CXCR3(+) conventional T cells in intestinal tumors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25754875%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25754875%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Paulina Akeus

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25754875%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Veronica Langenes

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25754875%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Jonas Kristensen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25754875%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Tim Sparwasser

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25754875%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Sukanya Raghavan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25754875%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Marianne Quiding-Järbrink

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25754875%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

language of work or name

English

0 references

publication date

14 April 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25754875%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

2 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25754875%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25754875%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25754875%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

1654-1666

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25754875%20AND%20SRC:MED&resulttype=core&format=json

Genetic and epigenetic biomarkers of colorectal cancer

2 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

Maintenance of adenomatous polyposis coli (APC)-mutant colorectal cancer is dependent on Wnt/beta-catenin signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

Cross-species comparison of human and mouse intestinal polyps reveals conserved mechanisms in adenomatous polyposis coli (APC)-driven tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

APC, signal transduction and genetic instability in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

Review article: antitumoural immunity in colorectal cancer - current and potential future implications in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

Regulatory T cells in gastrointestinal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

Regulatory T cells exert checks and balances on self tolerance and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

Regulatory T cells: mechanisms of differentiation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

Differences in tumor regulatory T-cell localization and activation status impact patient outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

High density of FOXP3-positive T cells infiltrating colorectal cancers with microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

Accumulation of CCR4⁺CTLA-4 FOXP3⁺CD25(hi) regulatory T cells in colon adenocarcinomas correlate to reduced activation of conventional T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

T-regulatory cells shift from a protective anti-inflammatory to a cancer-promoting proinflammatory phenotype in polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

Expression of RORγt marks a pathogenic regulatory T cell subset in human colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

Regulatory T cells in colorectal cancer patients suppress anti-tumor immune activity in a COX-2 dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

CD4+ CD25high regulatory T cells reduce T cell transendothelial migration in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

The canonical Wnt signaling pathway plays an important role in lymphopoiesis and hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

Activation of beta-catenin in dendritic cells regulates immunity versus tolerance in the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

Function and recruitment of mucosal regulatory T cells in human chronic Helicobacter pylori infection and gastric adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

T-cell trafficking facilitated by high endothelial venules is required for tumor control after regulatory T-cell depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

CCR6, the sole receptor for the chemokine CCL20, promotes spontaneous intestinal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

Conditional regulatory T-cell depletion releases adaptive immunity preventing carcinogenesis and suppressing established tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

Regulatory T cells: how do they suppress immune responses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

Biomolecular Network Reconstruction Identifies T-Cell Homing Factors Associated With Survival in Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

CXCL10 promotes invasion-related properties in human colorectal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

CXCR3+ T regulatory cells selectively accumulate in human ovarian carcinomas to limit type I immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

CXCL10 expression and prognostic significance in stage II and III colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

Adenomatous polyps are driven by microbe-instigated focal inflammation and are controlled by IL-10-producing T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

Controversies on the role of Th17 in cancer: a TGF-β-dependent immunosuppressive activity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

7 January 2021

Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

7 January 2021

High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

7 January 2021

Altered chemokine production and accumulation of regulatory T cells in intestinal adenomas of APCMin/+ mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

7 January 2021

Efficient Treg depletion induces T-cell infiltration and rejection of large tumors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

7 January 2021

Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445058

7 January 2021